Search

Author/Creator Baurain, Jean-Francois

1. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022)

Authors:
Lorusso, Domenica; Vergote, Ignace; O'Cearbhaill, Roisin E; Westermann, Anne M; Banerjee, Susana; van Nieuwenhuysen, Els; Iglesias, David A; Collins, Dearbhaile; Cibula, David; Madsen, Kristine; Tewari, Krishnansu S; Pignata, Sandro; Baurain, Jean-Francois; Boere, Ingrid A; Denys, Hannelore; Andr...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (20th October 2022)

Authors:
Concin, Nicole; Monk, Bradley J; Mirza, Mansoor Raza; Coleman, Robert L; Ray-Coquard, Isabelle; Pothuri, Bhavana; Baurain, Jean-Francois; Alejandro Perez-Fidalgo, J; Cibula, David; Saverse, Antonella; Banerjee, Susana; Madry, Radek; Marth, Christian; Putiri, Emily; Barrett, Jamie; DeMars, Leslie;...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 347 Efficacy and safety of niraparib in older patients (PTS) with advanced ovarian cancer (OC): results from the prima/ENGOT-OV26/GOG-3012 trial. (4th December 2020)

Authors:
Dahlstrand, Hanna; Pothuri, Bhavana; Graybill, Whitney; Rouge, Thibault de La Motte; Mccormick, Colleen; Heitz, Florian; Baurain, Jean-Francois; Yong, LI; Monk, Bradley J; González-Martin, Antonio
Journal:
International journal of gynecological cancer
Issue:
Volume 30(2020)Supplement 4
Page Start:
A69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors. (10th December 2020)

Authors:
Bechter, Oliver; Utikal, Jochen; Baurain, Jean-Francois; Massard, Christophe; Sahin, Ugur; Derhovanessian, Evelyna; Ozoux, Marie-Laure; Marpadga, Rahul; Imedio, Esteban-Rodrigo; Acquavella, Nicolas; Loquai, Carmen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. Issue 5 (May 2021)

Authors:
Coleman, Robert L; Lorusso, Domenica; Gennigens, Christine; González-Martín, Antonio; Randall, Leslie; Cibula, David; Lund, Bente; Woelber, Linn; Pignata, Sandro; Forget, Frederic; Redondo, Andrés; Vindeløv, Signe Diness; Chen, Menghui; Harris, Jeffrey R; Smith, Margaret; Nicacio, Leonardo Viana;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
609
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. (October 2019)

Authors:
Jones, Robin L.; Ratain, Mark J.; O'Dwyer, Peter J.; Siu, Lillian L.; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith M.P.G.M.; Evans, T.R. Jeffry; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jea...
Journal:
European journal of cancer
Issue:
Volume 120(2019)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗